tiprankstipranks
Trending News
More News >
Seelos Therapeutics (SEELQ)
OTHER OTC:SEELQ
US Market

Seelos Therapeutics (SEELQ) Income Statement

Compare
1,203 Followers

Seelos Therapeutics Income Statement

Last quarter (Q2 2024), Seelos Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Seelos Therapeutics's net income was $1.71M. See Seelos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 2.20M$ ―$ ―$ ―$ 151.00K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -37.75M$ -73.47M$ -64.45M$ -18.94M$ -51.23M
Operating Income
$ -40.50M$ -70.92M$ -61.67M$ -18.76M$ -34.99M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -37.88M$ -73.53M$ -66.05M$ -19.10M$ -51.26M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Seelos Therapeutics Earnings and Revenue History